Telix and Cyclotek Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand
Telix is pleased to announce the completion of a Master Services Agreement with Cyclotek (Aust) Pty Ltd…
Read moreNews & Views
Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies
Telix is pleased to announce a licence agreement collaboration with Abzena plc (Abzena) for its prostate-specific membrane antigen antibodies…
Read more
Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer
Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS…
Read more
Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia
Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG…
Read more